Apyx Medical Corporation

(NASDAQ:APYX)

Latest On Apyx Medical Corporation (APYX):

Date/Time Type Description Signal Details
2023-05-11 16:38 ESTNewsApyx Medical beats Q1 top and bottom line estimates; updates FY23 outlookN/A
2023-05-11 16:38 ESTNewsApyx Medical Corporation (APYX) Q1 2023 Earnings Call TranscriptN/A
2023-05-02 19:43 ESTNewsApyx gets FDA nod for Renuvion APR Handpiece use after liposuctionN/A
2023-04-28 16:44 ESTNewsApyx stock rises on FDA clearance of Renuvion APR HandpieceN/A
2023-03-16 14:18 ESTNewsApyx Medical GAAP EPS of -$0.17 misses by $0.03, revenue of $12.61M misses by $0.43MN/A
2023-03-16 14:18 ESTNewsApyx Medical Corporation (APYX) Q4 2022 Earnings Call TranscriptN/A
2023-02-27 11:31 ESTNewsApyx Medical wins FDA nod for Renuvion APR Handpiece in new indicationN/A
2023-02-21 21:30 ESTNewsApyx Medical to secure up to $35M credit on agreement with MidCap FinancialN/A
2023-02-01 13:44 ESTNewsApyx files for FDA expanded approval of Renuvion APR HandpieceN/A
2023-01-10 19:47 ESTNewsApyx Medical trims FY revenue guidance, guides Q4 and FY revenue outlook below estimatesN/A
2022-11-14 05:19 ESTNewsApyx Medical Corporation (APYX) Q3 2022 Earnings Call TranscriptN/A
2022-11-10 12:58 ESTNewsApyx Medical reports Q3 earnings miss; narrows FY22 revenue guidance below estimatesN/A
2022-11-10 12:56 ESTNewsApyx crashes 64% as Q3 sees prolonged impact on Advanced Energy products; cuts outlookN/A
2022-08-14 19:08 ESTNewsApyx Medical Corporation (APYX) CEO Charles Goodwin on Q2 2022 Results - Earnings Call TranscriptN/A
2022-08-11 22:51 ESTNewsApyx Medical GAAP EPS of -$0.16 beats by $0.03, revenue of $10.3M misses by $0.26MN/A
2022-07-18 08:28 ESTNewsApyx Medical gets FDA nod for Renuvion's use in improving loose skin on neck, chinN/A
2022-05-27 00:36 ESTNewsApyx Medical gains as FDA clears Renuvion for wrinkle reductionN/A
2022-05-13 07:05 ESTNewsApyx Medical Corporation (APYX) CEO Charles Goodwin on Q1 2022 Results - Earnings Call TranscriptN/A
2022-05-12 12:44 ESTNewsApyx Medical GAAP EPS of -$0.17, revenue of $12.5MN/A
2022-04-04 13:52 ESTNewsApyx Medical seeks FDA nod to expand use of Renuvion to improve lax skinN/A
2022-03-18 11:47 ESTNewsApyx Medical GAAP EPS of -$0.06 beats by $0.05, revenue of $16.82M beats by $0.47MN/A
2022-03-18 11:46 ESTNewsApyx Medical Corporation (APYX) CEO Charles Goodwin on Q4 2021 Results - Earnings Call TranscriptN/A
2022-03-14 23:38 ESTNewsApyx Medical sinks on safety concern for product technologyN/A
2022-01-10 15:39 ESTNewsApyx Medical to report over 40% growth in revenue, easily beat estimates: Q4 PrelimN/A
2021-11-12 16:46 ESTNewsApyx Medical Corp (APYX) CEO Charles Goodwin on Q3 2021 Results - Earnings Call TranscriptN/A
2021-09-21 12:09 ESTNewsApyx Medical EPS beats by $0.03, beats on revenueN/A
2021-08-12 12:16 ESTNewsApyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2021 Results - Earnings Call TranscriptN/A
2021-03-31 16:42 ESTNewsApyx Medical EPS beats by $0.12, beats on revenue; outlookN/A
2021-03-31 16:41 ESTNewsApyx Medical Corporation (APYX) CEO Charlie Goodwin on Q4 2020 Results - Earnings Call TranscriptN/A
2021-02-10 07:08 ESTAnalyst RatingThe Analyst Target Price has increased from $11.25 to $12.5.Buy
2021-02-01 07:08 ESTAnalyst RatingThe Analyst Target Price has increased from $10.25 to $11.25.Buy
2021-01-20 07:07 ESTAnalyst RatingThe Analyst Target Price has increased from $9.25 to $10.25.Buy
2021-01-15 07:07 ESTAnalyst RatingThe Analyst Target Price has increased from $8.75 to $9.25.Neutral
2021-01-14 00:48 ESTNewsApyx Medical rallies on Q4 and FY 2020 preliminary revenue resultsN/A
2020-12-13 03:12 ESTFinancialsCompany financials have been released.Neutral
2020-11-24 13:49 ESTNewsApyx Medical on go with Phase II of U.S. IDE studyN/A
2020-11-18 06:54 ESTNewsApyx Medical (APYX) Investor Presentation - SlideshowN/A
2020-11-15 11:13 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 19:11 ESTFinancialsCompany financials have been released.Neutral
2020-11-12 03:09 ESTFinancialsCompany financials have been released.Neutral
2020-11-10 11:12 ESTEarnings EstimateAn EPS average of -$0.14 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-10 11:12 ESTAnalyst RatingThe Analyst Target Price has increased from $8.25 to $8.75.Buy
2020-11-10 06:18 ESTNewsApyx Medical EPS beats by $0.06, beats on revenueN/A
2020-11-10 06:17 ESTNewsApyx Medical Corporation (APYX) CEO Charlie Goodwin on Q3 2020 Results - Earnings Call TranscriptN/A
2020-11-01 17:04 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 04:16 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 12:08 ESTFinancialsCompany financials have been released.Neutral
2020-08-12 04:09 ESTAnalyst RatingThe Analyst Target Price has increased from $7.75 to $8.25.Buy
2020-08-11 07:34 ESTNewsApyx Medical EPS beats by $0.07, beats on revenueN/A
2020-08-11 07:32 ESTNewsApyx Medical Corporation (APYX) CEO Charlie Goodwin on Q2 2020 Results - Earnings Call TranscriptN/A

About Apyx Medical Corporation (APYX):

Apyx Medical Corporation, a energy technology company, manufactures and sells medical devices in the cosmetic and surgical markets worldwide. It operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). The company develops J-Plasma, a patented plasma-based surgical product for cutting, coagulation, and ablation of soft tissue. It markets and sells Helium Plasma Technology under the Renuvion brand name in the cosmetic surgery market and under the J-Plasma brand name in the hospital surgical market. The company's Renuvion cosmetic technology enables plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue; and the J-Plasma system allows surgeons to operate in eliminating unintended tissue trauma. It also designs, develops, manufactures, and sells electrosurgical and OEM generators and related accessories for medical device manufacturers. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

APYX Quotes by TradingView

See Advanced Chart

General

  • Name Apyx Medical Corporation
  • Symbol APYX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryMedical Devices
  • Full Time Employees 266
  • Fiscal Year EndDecember
  • IPO Date1987-01-01
  • Gic SectorHealth Care
  • Gic GroupHealth Care Equipment & Services
  • Gic IndustryHealth Care Equipment & Supplies
  • Gic SubIndustryHealth Care Equipment
  • Web URLhttp://apyxmedical.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 15.18
  • Price/Book (Most Recent Quarter) 5.84
  • Enterprise Value Revenue 13.5
View More

Financials

  • Most Recent Quarter 2020-09-30
  • Next Quarter EPS Estimate -$0.15
  • Profit Margin -64%
  • Operating Margin -97%
  • Return on Assets -18%
  • Return on Equity -22%
  • Revenue 24.63 million
  • Earnings Per Share $1.68
  • Revenue Per Share $0.72
  • Gross Profit 19.09 million
  • Quarterly Earnings Growth -8.2%
View More

Highlights

  • Market Capitalization 359.54 million
  • EBITDA -16260000
  • Analyst Target Price $12.5
  • Book Value Per Share $1.88
View More

Share Statistics

  • Shares Outstanding 34.27 million
  • Shares Float 23.37 million
  • % Held by Insiders 1239%
  • % Held by Institutions 51.99%
  • Shares Short 623736
  • Shares Short Prior Month 565464
  • Short Ratio 7.41
  • Short % of Float 2%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 0.68
  • 52 Week High $12.01
  • 52 Week Low $2.81
  • 50 Day Moving Average 10.46
  • 200 Day Moving Average 7.58
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Apyx Medical Corporation (APYX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Apyx Medical Corporation (APYX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-09-302020-11-09$6.95 million-$0.11-$0.1733.33%
2020-06-302020-08-10$4.3 million-$0.14-$0.2134.12%
2020-03-312020-05-11$5 million-$0.06-$0.2576%
2019-12-312020-03-16$8.38 million-$0.16-$0.1917.23%
2019-09-302019-11-11$7.58 million-$0.13-$0.1827.78%
2019-06-302019-08-07$6.57 million-$0.13-$0.1826.76%
2019-03-312019-05-08$5.82 million-$0.14-$0.1716.02%
2018-12-312019-03-13$5.93 million-$0.12-$0.10-17.07%
2018-09-302018-11-01$3.67 million$1.98-$0.092240.54%
2018-06-302018-08-01$11.48 million-$0.01-$0.0366.67%
2018-03-312018-05-14$9.92 million-$0.03-$0.02-28.76%
2017-12-312018-03-12$11.35 million-$0.03-$0.0753.85%
2017-09-302017-11-02$9.35 million-$0.04-$0.01-200.75%
2017-06-302017-08-02$9.8 million-$0.04-$0.03-20.12%
2017-03-312017-05-15$8.39 million-$0.05-$0.04-42.86%
2016-12-312017-03-09$9.49 million-$0.02-$0.01-100%
2016-09-302016-10-26$10.06 million-$0.04-$0.03-60%
2016-06-302016-08-01$9.3 million-$0.02-$0.0663.64%
2016-03-312016-05-11$7.78 million-$0.07-$0.06-27.27%
2015-12-312016-03-17$8.29 million-$0.05-$0.0723.08%
2015-09-302015-11-04$7.82 million-$0.07-$0.06-16.67%
2015-06-302015-08-06$7.27 million-$0.06-$0.0933.33%
2015-03-312015-05-08$6.13 million-$0.14-$0.10-40%
2014-12-312015-02-27$7.47 million-$0.27
2014-09-302014-11-06$6.79 million-$0.17
2014-06-302014-08-05$6.95 million-$0.03-$0.02-50%
2014-03-312014-05-15$6.48 million-$0.01-$0.0580%
2013-09-302013-11-14$5.79 million-$0.02
2013-06-302013-08-14$6.04 million-$0.06
2013-03-312013-04-01$5.7 million$0.02$0.020%
2012-12-312013-03-31$6.83 million$0.02$0.020%
2012-09-302012-11-14$6.67 million$-0.00
2012-06-302012-08-14$7.44 million$0.01
2012-03-312012-05-15$6.73 million$0.01
2011-12-312012-03-29$6.16 million-$0.05
2011-09-302011-11-14$6.26 million$0.00
2011-06-302011-08-12$6.84 million$0.02
2011-03-312011-05-12$6.15 million$0.03
2010-09-302010-11-09$6.5 million$0.00
2010-06-302010-08-09$5.9 million$0.00
2010-03-312010-05-10$5.6 million-$0.01
2009-12-312010-03-16$6.53 million$0.00
2009-09-302009-11-09$6.37 million$-0.00$0.01-121%
2009-06-302009-08-10$6.83 million$0.01$0.02-50%
2009-03-312009-05-08$7.22 million$0.02
2008-09-302008-11-10$7.3 million$0.02
2008-06-302008-08-13$6.99 million$0.08
2008-03-312008-05-14$6.68 million$0.01
2007-09-302007-11-12$7.46 million$0.03
2007-06-302007-08-10$7.44 million$0.06
2007-03-312007-05-15$6.7 million$0.03
2006-09-302006-11-07$7 million$0.05
2006-06-302006-08-09$6.74 million$0.04
2006-03-312006-05-10$6.01 million$0.04
2005-12-312006-03-29$5.37 million$0.02
2005-09-302005-11-14$5.04 million$0.01
2005-06-302005-08-15$5.06 million-$0.01
2005-03-312005-05-13$4.74 million$0.01
2004-12-312005-03-29$4.87 million$0.02
2004-09-302004-11-14$5.62 million$0.03
2004-06-302004-08-15$5.27 million$0.03
2004-03-312004-05-13$4.74 million$0.01
2003-12-312004-03-30$4.12 million-$0.02
2003-09-302003-11-03$4.04 million$0.03
2003-06-302003-07-30$4.28 million$0.03
2003-03-312003-03-31$3.67 million$0.00
2002-09-302002-09-30$3.05 million$-0.00
2002-06-302002-06-30$3.2 million$-0.00
2002-03-312002-03-31$3.03 million$-0.00
2001-09-302001-09-30$2.78 million$0.02
2001-06-302001-06-30$2.82 million$0.01
2001-03-312001-03-31$2.74 million$0.01
2000-09-302000-09-30$2.49 million$0.01
2000-06-302000-06-30$2.43 million$0.02
2000-03-312000-03-31$2.17 million$0.00
1999-09-301999-09-30-$0.11
1999-06-301999-06-30$0.01
1999-03-311999-03-31$0.00
1998-03-311998-03-31-$0.01

Apyx Medical Corporation (APYX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Apyx Medical Corporation (APYX) Chart:

APYX chart by TradingView

Apyx Medical Corporation (APYX) News:

Below you will find a list of latest news for Apyx Medical Corporation (APYX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Apyx Medical Corporation (APYX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-172.50.05CALL0 1000FALSE00
2024-05-1750.1CALL0 2510FALSE00
2024-05-177.50.2CALL0 20FALSE00
2024-05-172.50.9PUT0 60168.16TRUE00
2024-05-1750PUT0 0371.79TRUE00
2024-05-177.50PUT0 0449.22TRUE00
2024-06-212.50.05CALL0 10110FALSE00
2024-06-2150.05CALL0 130FALSE00
2024-06-217.50.2CALL0 50FALSE00
2024-06-212.50.85PUT0 51108.55TRUE00
2024-06-2150PUT0 0236.94TRUE00
2024-06-217.50PUT0 0288.13TRUE00
2024-08-162.50.15CALL0 11117.53FALSE00
2024-08-1650CALL0 00FALSE00
2024-08-167.50CALL0 00FALSE00
2024-08-162.50PUT0 0103.27TRUE00
2024-08-1650PUT0 0150.3TRUE00
2024-08-167.50PUT0 0215.18TRUE00
2024-11-152.50CALL0 0110.09FALSE00
2024-11-1550CALL0 0121.26FALSE00
2024-11-157.50CALL0 00FALSE00
2024-11-152.50PUT0 0106.63TRUE00
2024-11-1550PUT0 0120.84TRUE00
2024-11-157.50PUT0 0151.95TRUE00
2024-12-202.50.3CALL0 4023111.85FALSE00
2024-12-2050.6CALL0 109125.66FALSE00
2024-12-207.50.15CALL0 35130FALSE00
2024-12-202.50PUT0 099.94TRUE00
2024-12-2053.5PUT0 10114.45TRUE00
2024-12-207.50PUT0 0144.01TRUE00

Latest APYX Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST21$6.215
Jun 13, 2022 7:59 PM EST100$6.215
Jun 13, 2022 7:59 PM EST100$6.215
Jun 13, 2022 7:59 PM EST100$6.215
Jun 13, 2022 7:59 PM EST100$6.215

Apyx Medical Corporation (APYX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/719135/000071913520000051/0000719135-20-000051-index.htm
2018-05-09UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/719135/000000000018014465/0000000000-18-014465-index.htm
2017-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913517000067/0000719135-17-000067-index.htm
2017-12-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913517000070/0000719135-17-000070-index.htm
2018-01-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000002/0000719135-18-000002-index.htm
2018-01-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000004/0000719135-18-000004-index.htm
2018-01-23S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000008/0000719135-18-000008-index.htm
2018-03-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000013/0000719135-18-000013-index.htm
2018-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/719135/000071913518000015/0000719135-18-000015-index.htm
2018-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000017/0000719135-18-000017-index.htm
2018-04-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000019/0000719135-18-000019-index.htm
2018-05-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000021/0000719135-18-000021-index.htm
2018-05-04S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/719135/000071913518000024/0000719135-18-000024-index.htm
2018-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000028/0000719135-18-000028-index.htm
2018-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913518000030/0000719135-18-000030-index.htm
2018-05-16S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/719135/000071913518000035/0000719135-18-000035-index.htm
2018-05-16CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/719135/000071913518000037/0000719135-18-000037-index.htm
2018-05-24SDhttps://www.sec.gov/Archives/edgar/data/719135/000071913518000039/0000719135-18-000039-index.htm
2018-07-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000044/0000719135-18-000044-index.htm
2018-07-17PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000046/0000719135-18-000046-index.htm
2018-07-27DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000050/0000719135-18-000050-index.htm
2018-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000054/0000719135-18-000054-index.htm
2018-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913518000055/0000719135-18-000055-index.htm
2018-08-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000057/0000719135-18-000057-index.htm
2018-09-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000059/0000719135-18-000059-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000065/0000719135-18-000065-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000066/0000719135-18-000066-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000067/0000719135-18-000067-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000068/0000719135-18-000068-index.htm
2018-09-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000069/0000719135-18-000069-index.htm
2018-11-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000073/0000719135-18-000073-index.htm
2018-11-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913518000076/0000719135-18-000076-index.htm
2018-11-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000078/0000719135-18-000078-index.htm
2018-11-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000080/0000719135-18-000080-index.htm
2018-12-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000082/0000719135-18-000082-index.htm
2018-12-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000084/0000719135-18-000084-index.htm
2018-12-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913518000086/0000719135-18-000086-index.htm
2018-12-3125Notification of the removal from listing and registration of matured, redeemed or retired securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913518000089/0000719135-18-000089-index.htm
2018-12-318-A12B/ARegistration of securities [Section 12(b)]https://www.sec.gov/Archives/edgar/data/719135/000071913518000090/0000719135-18-000090-index.htm
2019-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000004/0000719135-19-000004-index.htm
2019-01-113Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000006/0000719135-19-000006-index.htm
2019-01-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000008/0000719135-19-000008-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000010/0000719135-19-000010-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000012/0000719135-19-000012-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000014/0000719135-19-000014-index.htm
2019-02-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000016/0000719135-19-000016-index.htm
2019-05-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913519000019/0000719135-19-000019-index.htm
2019-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000020/0000719135-19-000020-index.htm
2019-05-31SDhttps://www.sec.gov/Archives/edgar/data/719135/000071913519000022/0000719135-19-000022-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000025/0000719135-19-000025-index.htm
2019-06-21DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000027/0000719135-19-000027-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000029/0000719135-19-000029-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000031/0000719135-19-000031-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000033/0000719135-19-000033-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000035/0000719135-19-000035-index.htm
2019-08-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000037/0000719135-19-000037-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000038/0000719135-19-000038-index.htm
2019-08-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913519000039/0000719135-19-000039-index.htm
2019-08-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000040/0000719135-19-000040-index.htm
2019-08-153Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000042/0000719135-19-000042-index.htm
2019-09-27S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/719135/000071913519000044/0000719135-19-000044-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000047/0000719135-19-000047-index.htm
2019-10-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000048/0000719135-19-000048-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000053/0000719135-19-000053-index.htm
2019-11-13NT 10-QNotification of inability to timely file Form 10-Q or 10-QSBhttps://www.sec.gov/Archives/edgar/data/719135/000071913519000056/0000719135-19-000056-index.htm
2019-11-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913519000060/0000719135-19-000060-index.htm
2019-12-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913519000063/0000719135-19-000063-index.htm
2020-01-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000002/0000719135-20-000002-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000007/0000719135-20-000007-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000008/0000719135-20-000008-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000009/0000719135-20-000009-index.htm
2020-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000010/0000719135-20-000010-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000012/0000719135-20-000012-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000014/0000719135-20-000014-index.htm
2020-03-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000016/0000719135-20-000016-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000022/0000719135-20-000022-index.htm
2020-03-16NT 10-KNotification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405https://www.sec.gov/Archives/edgar/data/719135/000071913520000023/0000719135-20-000023-index.htm
2020-03-198-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000026/0000719135-20-000026-index.htm
2020-03-3110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/719135/000071913520000029/0000719135-20-000029-index.htm
2020-05-0810-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913520000035/0000719135-20-000035-index.htm
2020-05-0810-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913520000036/0000719135-20-000036-index.htm
2020-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000042/0000719135-20-000042-index.htm
2020-05-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913520000043/0000719135-20-000043-index.htm
2020-05-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000045/0000719135-20-000045-index.htm
2020-06-01SDhttps://www.sec.gov/Archives/edgar/data/719135/000071913520000047/0000719135-20-000047-index.htm
2020-06-26DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000049/0000719135-20-000049-index.htm
2020-06-30DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/719135/000071913520000051/0000719135-20-000051-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000054/0000719135-20-000054-index.htm
2020-08-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/719135/000071913520000057/0000719135-20-000057-index.htm
2020-08-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000058/0000719135-20-000058-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000059/0000719135-20-000059-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000060/0000719135-20-000060-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000061/0000719135-20-000061-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000062/0000719135-20-000062-index.htm
2020-08-104Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000071913520000063/0000719135-20-000063-index.htm
2020-08-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000067/0000719135-20-000067-index.htm
2020-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000071913520000070/0000719135-20-000070-index.htm
2020-02-07SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000083423720007976/0000834237-20-007976-index.htm
2018-02-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000091957418000970/0000919574-18-000970-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000091957419001301/0000919574-19-001301-index.htm
2019-04-08SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000091957419002790/0000919574-19-002790-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000091957420001138/0000919574-20-001138-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000093041318000476/0000930413-18-000476-index.htm
2018-02-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000119312518037488/0001193125-18-037488-index.htm
2019-01-18SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000119312519011979/0001193125-19-011979-index.htm
2020-01-09SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000119312520004330/0001193125-20-004330-index.htm
2019-01-02CERTCertificationhttps://www.sec.gov/Archives/edgar/data/719135/000135445719000001/0001354457-19-000001-index.htm
2018-01-09SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000149315218000367/0001493152-18-000367-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000149315218002078/0001493152-18-002078-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000149315219001943/0001493152-19-001943-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/719135/000149315220002398/0001493152-20-002398-index.htm
2019-01-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000162828019000624/0001628280-19-000624-index.htm
2019-03-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000162828019002891/0001628280-19-002891-index.htm
2019-03-1410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/719135/000162828019002892/0001628280-19-002892-index.htm
2019-04-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000162828019003915/0001628280-19-003915-index.htm
2019-04-268-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/719135/000162828019004808/0001628280-19-004808-index.htm
2018-09-27144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000168499518000013/0001684995-18-000013-index.htm
2019-01-28144Report of proposed sale of securitieshttps://www.sec.gov/Archives/edgar/data/719135/000168499519000001/0001684995-19-000001-index.htm
2018-05-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/719135/999999999518001275/9999999995-18-001275-index.htm

Apyx Medical Corporation (APYX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Apyx Medical Corporation (APYX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1239%
Institutional Ownership: 5199%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2020-05-13Charles D. II GoodwinChief Executive OfficerBuy28,250.003.3093,196.7528,250.00https://www.sec.gov/Archives/edgar/data/719135/000071913520000045/0000719135-20-000045-index.htm